Genetic analysis for CDH1 gene mutation (full sequence)
This test checks for changes (mutations) in the CDH1 gene, which is linked to hereditary diffuse gastric cancer syndrome. Early detection may help guide prevention or monitoring strategies.
["This test helps assess risk for a rare but serious inherited condition."]
Key facts at a glance
- LOINC
- 94240-9
- Short code
- CDH1
- Synonyms
- CDH1 gene Del+Dup + Full Mut Anl Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (lavender-top) whole blood tube for peripheral blood; sterile container with appropriate transport medium for tissue specimens
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–99 years
- Method
- molgen
- CPT
- 81432; 81433 (full gene sequence analysis); 81479 (deletion/duplication analysis, unlisted molecular pathology)
- SNOMED
- 446080008
- Specimen volume
- 3-5 mL whole blood or 5-10 mg fresh/frozen tissue
- Stability
- Whole blood: Ambient 24-48 hours, refrigerated (2-8°C) up to 7 days; do not freeze whole blood. Tissue: Frozen (-20°C or lower) for long-term storage. Extracted DNA: stable at 2-8°C for 1 month, -20°C for long-term.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 336–720 hours
- Order
- routine
What This Test Measures
The CDH1 gene provides instructions for making a protein called E-cadherin, which helps cells stick together. Mutations in this gene can disrupt normal cell function and increase cancer risk. This test examines the entire gene sequence to identify any inherited changes.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have a family history of stomach cancer, colorectal cancer, or other related cancers, or if you meet specific genetic risk criteria.
Sample Collection and Process
A blood sample is typically used to collect DNA for genetic testing. The lab processes the sample to analyze the CDH1 gene for any mutations that may be present.
What to Expect After the Test
Results will be reviewed by a genetic counselor or specialist. You’ll receive detailed information about whether mutations were found and their potential implications for your health and family.
Reference range
No pathogenic CDH1 sequence variants, deletions, or duplications detected. Interpretation reported as Positive (pathogenic variant identified), Negative (no pathogenic variant identified), or Variant of Uncertain Significance (VUS).N/A
No special preparation or fasting required. Patients should provide informed consent for genetic testing. Pre-test genetic counseling is recommended. A documented clinical and family history of gastric and/or lobular breast cancer supports clinical interpretation.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Mutations in the CDH1 gene are associated with an increased risk of developing stomach (gastric) cancer and possibly colorectal cancer. Early detection and monitoring can help manage risk through lifestyle changes, surveillance, or preventive measures like endoscopic screenings.
Short name
CDH1 Gene Mutation Test
Frequently asked questions
What does a positive result mean?
Will this test affect my insurance or ability to get treatment?
Can I get this test if I don’t have a family history of cancer?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy